TargetMol

Homatropine Methylbromide

Product Code:
 
TAR-T0427
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T0427-25mg25mg£99.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0427-50mg50mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0427-1mL1 mL * 10 mM (in DMSO)£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0427-100mg100mg£118.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0427-200mg200mg£143.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T0427-500mg500mg£179.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Homatropine Methylbromide is the methyl bromide salt of homatropine, a synthetic tertiary amine alkaloid with antimuscarinic properties.
CAS:
80-49-9
Formula:
C17H24BrNO3
Molecular Weight:
370.287
Pathway:
Neuroscience
Purity:
1
SMILES:
[Br-].C[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)c1ccccc1
Target:
AChR

References

1. Sim MK, et al. Clin Exp Hypertens, 1993, 15(2), 409-421. 2. Leung E, et al. Eur J Pharmacol, 1982, 80(1), 11-17. 3. Gilani SA, et al. Arch Int Pharmacodyn Ther, 1987, 290(1), 46-53. 4. Bryant SM, et al. J Med Toxicol, 2006, 2(4), 156-159. 5. Cramer MB, et al. J Pharm Pharmacol, 1978, 30(5), 284-286.